Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period

Aim. To identify factors responsible for the early development of microvascular complications in patients with type 1 diabetes mellitus (DM1)and to evaluate dependence of their prevalence on the type of insulin. Materials and methods. The study carried out from May 2002 to November 2007 included a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lyubov' Leonidovna Bolotskaya, Yury Ivanovich Suntsov, Igor Vladislavovich Kazakov, Marina Vladimirovna Shestakova, Ivan Ivanovich Dedov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2009
Materias:
Acceso en línea:https://doaj.org/article/3c4494d28b2e46889fe6ad97da38d647
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3c4494d28b2e46889fe6ad97da38d647
record_format dspace
spelling oai:doaj.org-article:3c4494d28b2e46889fe6ad97da38d6472021-11-14T09:00:14ZEfficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period2072-03512072-037810.14341/2072-0351-5452https://doaj.org/article/3c4494d28b2e46889fe6ad97da38d6472009-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5452https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To identify factors responsible for the early development of microvascular complications in patients with type 1 diabetes mellitus (DM1)and to evaluate dependence of their prevalence on the type of insulin. Materials and methods. The study carried out from May 2002 to November 2007 included a random sample of patients with DM1 over 10 years in duration(n=5895, 100%, >=20 years) from the Central, Volga, Ural, Siberian, North-West and Southern federal districts. All patients underwentexamination of eye fundus and feet, measurement of microalbuminuria, creatinine, urea, serum lipid spectrum and HbА1с. Results. Mean HbА1с level in patients of group 1 (using insulin analogs) was significantly lower than in group 2 (using homan insulin) (Me 8,5?0,2%;9,7?0,4% SD* respectively) p>0,01. Mean daily insulin dose in group 1 and 2 was >1,0 andLyubov' Leonidovna BolotskayaYury Ivanovich SuntsovIgor Vladislavovich KazakovMarina Vladimirovna ShestakovaIvan Ivanovich DedovEndocrinology Research Centrearticlestate diabetes registryglycated hemoglobinone-step epidemiological surveyinsulin analogsdiabetic nephropathydiabetic retinopathydiabetic foot syndromedelayed physical developmentNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 12, Iss 3, Pp 49-52 (2009)
institution DOAJ
collection DOAJ
language EN
RU
topic state diabetes registry
glycated hemoglobin
one-step epidemiological survey
insulin analogs
diabetic nephropathy
diabetic retinopathy
diabetic foot syndrome
delayed physical development
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle state diabetes registry
glycated hemoglobin
one-step epidemiological survey
insulin analogs
diabetic nephropathy
diabetic retinopathy
diabetic foot syndrome
delayed physical development
Nutritional diseases. Deficiency diseases
RC620-627
Lyubov' Leonidovna Bolotskaya
Yury Ivanovich Suntsov
Igor Vladislavovich Kazakov
Marina Vladimirovna Shestakova
Ivan Ivanovich Dedov
Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
description Aim. To identify factors responsible for the early development of microvascular complications in patients with type 1 diabetes mellitus (DM1)and to evaluate dependence of their prevalence on the type of insulin. Materials and methods. The study carried out from May 2002 to November 2007 included a random sample of patients with DM1 over 10 years in duration(n=5895, 100%, >=20 years) from the Central, Volga, Ural, Siberian, North-West and Southern federal districts. All patients underwentexamination of eye fundus and feet, measurement of microalbuminuria, creatinine, urea, serum lipid spectrum and HbА1с. Results. Mean HbА1с level in patients of group 1 (using insulin analogs) was significantly lower than in group 2 (using homan insulin) (Me 8,5?0,2%;9,7?0,4% SD* respectively) p>0,01. Mean daily insulin dose in group 1 and 2 was >1,0 and
format article
author Lyubov' Leonidovna Bolotskaya
Yury Ivanovich Suntsov
Igor Vladislavovich Kazakov
Marina Vladimirovna Shestakova
Ivan Ivanovich Dedov
author_facet Lyubov' Leonidovna Bolotskaya
Yury Ivanovich Suntsov
Igor Vladislavovich Kazakov
Marina Vladimirovna Shestakova
Ivan Ivanovich Dedov
author_sort Lyubov' Leonidovna Bolotskaya
title Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
title_short Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
title_full Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
title_fullStr Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
title_full_unstemmed Efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
title_sort efficiency of insulin analogs in young patients with type 1 diabetes mellitus debut during pubertal period
publisher Endocrinology Research Centre
publishDate 2009
url https://doaj.org/article/3c4494d28b2e46889fe6ad97da38d647
work_keys_str_mv AT lyubovleonidovnabolotskaya efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod
AT yuryivanovichsuntsov efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod
AT igorvladislavovichkazakov efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod
AT marinavladimirovnashestakova efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod
AT ivanivanovichdedov efficiencyofinsulinanalogsinyoungpatientswithtype1diabetesmellitusdebutduringpubertalperiod
_version_ 1718429642350657536